Tumor reactivity cell scores are higher in CD8+ T cells from tumors of smokers than from tumors of non-smokers (P = 0.002) and are higher in wild-type EGFR tumors than in mutated tumors (P = 0.180; Fig. 6e). This evidence concerns the gene EGFR and neoplasm.